Table 1 Characteristics of healthy controls and AL patients
From: Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
Group | Number | Median age (range) | Gender (M/F) | Low risk | Medium risk | High risk | No data |
|---|---|---|---|---|---|---|---|
AL | 102 | 43 (5–85) | 48/54 | 5 | 9 | 36 | 52 |
AML | 57 | 52 (5–85) | 27/30 | 5 | 9 | 18 | 25 |
AML-ND | 17 | 60 (16–85) | 8/9 | 1 | 4 | 3 | 9 |
AML-CR | 13 | 50 (5–71) | 3/10 | 3 | 2 | 3 | 5 |
AML-NR | 27 | 52 (17–78) | 16/11 | 1 | 3 | 12 | 11 |
ALL | 45 | 26 (5–72) | 21/24 | 0 | 0 | 18 | 27 |
ALL-ND | 12 | 33 (12–70) | 6/6 | 0 | 0 | 6 | 6 |
ALL-CR | 12 | 25 (7–72) | 4/8 | 0 | 0 | 2 | 10 |
ALL-NR | 21 | 26 (5–62) | 11/10 | 0 | 0 | 10 | 11 |
Healthy controls | 28 | 42 (24–60) | 12/16 |